Single HPV Vaccine Dose Shows Similar Protection to Two Doses in Recent Study
A recent study indicates that a single dose of the HPV vaccine demonstrates comparable effectiveness to the standard two-dose regimen in preventing HPV infection. The study suggests a potential reduction in the number of doses required for effective immunization against the virus. Researchers observed that individuals who received a single dose of the HPV vaccine exhibited similar levels of protection against HPV infection as those who received the two-dose series. The findings offer the possibility of simplifying vaccination schedules and potentially improving vaccine access and coverage rates.
Newsflash | Powered by GeneOnline AI
Date: April 28, 2025
LATEST
VintaBio Showcases High-Yield VintaProcess Platform for Gene Therapy Vector Production at ASGCT 2025
2025-05-15
Boehringer Ingelheim and Tempus AI Partner in Multi-Year Collaboration to Enhance Oncology Drug Development
2025-05-15
Study: Aligning U.S. Drug Prices with Europe Could Reduce American Life Expectancy by Six Months
2025-05-15